Skip to main content
☕️ Baby guaranteed
To:Brew Readers
Healthcare Brew // Morning Brew // Update
Or your money back. That’s this IVF startup’s motto, anyway.

Hi, again. Feeling spacy? You (and Katy Perry) aren’t alone. A “space startup” announced last week it has raised a cumulative $329 million to continue manufacturing drugs in space. That’s one way to avoid dealing with looming pharmaceutical tariffs.

In today’s edition:

IVF refund policy

Getting psilocybin with it

Show me the money

—Caroline Catherman, Karen Fischer, Nicole Ortiz

WOMEN’S HEALTH

Headshot of Future Family Claire Tomkins

Future Family

Getting pregnant can be more expensive than a new car. Don’t believe us? Ask someone who’s done in vitro fertilization (IVF).

According to fertility education site FertilityIQ, a single IVF cycle is $23,000+ depending on location and whether services like medication and pre-implantation genetic screening are included. Patients complete an average of 2.3 to 2.7 cycles, which can total up to $50,000.

And it’s a growing industry: The US fertility industry is set to increase from $5.3 billion in 2023 to $8.7 billion by 2033, according to market research and consulting firm Precedence Research.

Some clinics and startups help patients finance these expensive fertility treatments, and offer programs that provide refunds if IVF is unsuccessful.

San Francisco-based startup Future Family offers both. The company introduced an insurance program in February with a “baby or your money back” guarantee. If a patient using the company’s IVF insurance doesn’t have a live birth after two cycles, they can file a claim and get a refund up to their coverage limit. Depending on the policy, that can be $15,000, $30,000, or $50,000.

Learn more about what Future Family is doing here.—CC

Presented By HealthEdge

PSYCHEDELICS

person with hands in their lap on left, brain and a hand holding mushrooms on right

Illustration: Brittany Holloway-Brown, Photos: Adobe Stock

Though UK-based pharmaceutical company Compass Pathways reached its primary endpoint from its June 23 Phase 3 trial to use synthetic psilocybin for treatment-resistent depression (TRD), investors were seemingly underwhelmed. That same day, shares plunged 46% to a record low of $2.35 a share for the biotech firm.

But Kabir Nath, CEO of Compass, defends the results of the trial, telling Healthcare Brew the team isn’t focused on share prices. The results are significant, he said, and ample bipartisan support in the Trump administration means this changes nothing about the quest for more research into psilocybin to treat certain mental health disorders.

The psychedelic healthcare market has been ramping up since June 2023 when the FDA issued new guidelines for biopharmaceutical firms interested in pursuing research on psychedelic drugs to treat psychiatric and substance use disorders. The three main drug compounds of interest were psilocybin, LSD, and MDMA.

Trial deets. Trial participants were patients with TRD—a diagnosis given after first-line treatments such as antidepressants fail two or more times to manage symptoms—and were living with multiple episodes of chronic depression for an average of three years.

Could psilocybin treatment finally be on the horizon?—KF

PROVIDERS

A 2D animation of a hospital with a bunch of pharma pills and dollar bill signs coming out of the top of it

Amelia Kinsinger

Though Medicaid cuts in the Trump administration’s budget bill shocked hospitals, providers may start singing its praises after learning they’re due for a pay bump next year.

On Monday, the Centers for Medicare and Medicaid Services (CMS) shared its proposed 2026 physician fee schedule, which determines Medicare payments based on the amount of resources in provider services like office visits, hospice, diagnostic testing, ambulance care, and more.

The budget bill calls for a 2.5% raise, and this also accounts for a 0.55% adjustment in proposed changes to certain services, according to a CMS fact sheet. Last year, Medicare paid $32.35 per relative value unit for qualifying physician services; next year’s rate is set at $33.59. For nonqualifying services, it’ll grow from $32.35 to $33.42.

Put simply? Physicians will get a more than 3.6% increase to this year’s salaries.

See all the deets here.—NO

Together With Zelis

VITAL SIGNS

A laptop tracking vital signs is placed on rolling medical equipment.

Francis Scialabba

Today’s top healthcare reads.

Stat: 16.5 million. That’s how many people have contacted the 988 suicide and crisis lifeline since it launched in 2022. (KFF)

Quote: “We could be ending AIDS. Instead, the US is abandoning the fight.”—Peter Maybarduk, access to medicines director of advocacy group Public Citizen, on US funding cuts to global HIV/AIDS programs (the Associated Press)

Read: For-profit rehab facilities have had “rare but serious” harmful incidents, but federal health officials haven’t informed the public or imposed fines, one investigation found. (the New York Times)

Planning ahead: HealthEdge helps health plans bring clinical and administrative data together on one integrated platform. As your organization grows, you can scale, streamline operations, and keep people at the center of care. Learn more.*

*A message from our sponsor.

CRISPR is revolutionizing medicine—from curing genetic diseases to reshaping research—but groundbreaking treatments come with high costs, complex logistics, and tough ethical questions. Explore the cutting-edge science behind gene editing and the challenges that lie ahead.

Check it out

JOBS

Real jobs, shared through real communities. CollabWORK brings opportunities directly to Healthcare Brew readers—no mass postings, no clutter, just roles worth seeing. Click here to view the full job board.

SHARE THE BREW

Share Healthcare Brew with your coworkers, acquire free Brew swag, and then make new friends as a result of your fresh Brew swag.

We're saying we'll give you free stuff and more friends if you share a link. One link.

Your referral count: 5

Click to Share

Or copy & paste your referral link to others:
https://www.healthcare-brew.com/r?kid=9ec4d467

         
ADVERTISE // CAREERS // SHOP // FAQ

Update your email preferences or unsubscribe here.
View our privacy policy here.

Copyright © 2025 Morning Brew Inc. All rights reserved.
22 W 19th St, 4th Floor, New York, NY 10011

Navigate the healthcare industry

Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.

A mobile phone scrolling a newsletter issue of Healthcare Brew